Genetics, Inheritance, and Biological Diagnosis
At a Glance
GATA6 syndrome results from a change in the GATA6 gene that can disrupt development of the pancreas and heart. Most cases are new in the child, but a healthy parent may have the change in only some cells. Genetic testing and counseling can confirm the diagnosis and clarify family risk.
Understanding GATA6 syndrome requires looking at the very earliest days of development. The GATA6 gene acts as a biological architect, providing the blueprints for how a cluster of stem cells should transform into complex organs like the heart and pancreas [1][2]. When this gene is mutated, those blueprints are interrupted, leading to the various physical challenges your child may face.
A Quick Glossary of Terms
- Transcription Factor: A protein (like GATA6) that turns other genes “on” or “off.”
- Endoderm & Mesoderm: The early cell layers in an embryo that eventually become the digestive system and heart.
- Mosaicism: When a genetic mutation is present in only some of a person’s cells, rather than all of them.
- Next-Generation Sequencing (NGS): Advanced DNA testing that reads many genes at once.
The Biological “Blueprint” Error
In the first few weeks of pregnancy, a developing embryo forms a layer of cells called the endoderm (which becomes the digestive system) and mesoderm (which becomes the heart and muscles) [1][3]. The GATA6 protein is a transcription factor, a protein that turns other genes “on” or “off” to guide this process [2].
- In the Pancreas: GATA6 works with other proteins to tell stem cells to become pancreatic progenitors—the “starter cells” for the pancreas [4]. If GATA6 is missing or not working correctly, the body may fail to create enough of these starter cells, resulting in a pancreas that is small (hypoplasia) or missing entirely (agenesis) [1][5].
- In the Heart: GATA6 helps pattern the “outflow tract,” the area where the major blood vessels leave the heart [2]. Without its guidance, these vessels may not connect properly, leading to structural defects like truncus arteriosus or holes in the heart walls [3][6].
How the Syndrome is Inherited
Most cases of GATA6 syndrome are de novo, meaning the mutation occurred spontaneously in the child and was not passed down from the parents [7][8]. However, because the syndrome is rare, researchers are still uncovering exactly how often it is inherited versus new.
- Autosomal Dominant: This condition is “dominant,” meaning a person only needs one mutated copy of the GATA6 gene to potentially show symptoms, due to variable penetrance [7].
- Parental Mosaicism: Occasionally, a parent may appear perfectly healthy but carry the GATA6 mutation in only a small percentage of their cells [7]. This is called mosaicism. Because the mutation isn’t in all their cells, they may have no symptoms, but they can still pass the mutation to their children [7]. For this reason, doctors recommend genetic testing for both biological parents even if they have no history of heart or blood sugar issues [9]. A negative blood test does not fully exclude germline mosaicism. Recurrence risk counseling should be individualized by a genetics professional.
Confirming the Diagnosis
Because several different genetic conditions can cause neonatal diabetes or a missing pancreas, doctors use a combination of tools to confirm a GATA6 diagnosis.
- Genetic Sequencing: The “gold standard” for diagnosis is Next-Generation Sequencing (NGS) [10]. This can be done via a “neonatal diabetes panel” that looks at dozens of genes at once, or Whole-Exome Sequencing (WES), which scans all the protein-coding genes in the body [11][5]. Note that standard sequencing may sometimes miss copy-number changes or low-level mosaicism, and a variant of uncertain significance (VUS) is not diagnostic.
- Imaging: To see the physical structure of the pancreas and heart, doctors use:
- MRI or CT Scans: These provide a detailed look at the abdomen to see if the “neck, body, or tail” of the pancreas is present [8][6]. CT scans involve ionizing radiation, and advanced imaging is only ordered to answer specific clinical questions rather than routinely.
- MRCP: A specialized MRI that looks specifically at the bile ducts and pancreatic ducts to check for blockages or malformations [12].
- Echocardiogram: An ultrasound of the heart used to identify structural defects [13].
- Lab Tests: Doctors measure C-peptide (to see how much insulin the body is making) and fecal elastase (to check if the pancreas is producing digestive enzymes, though this can be misleading in watery stool) [8][14].
Differentiating from “Look-Alikes”
GATA6 is unique because it so frequently involves both the heart and the pancreas, but other genes can mimic some of its features. Establishing the exact gene is vital because it changes the long-term management plan [15].
| Gene | Key Differences from GATA6 |
|---|---|
| GATA4 | Very similar to GATA6, often involving heart defects and a small pancreas, but may have different effects on the liver or diaphragm [15][16]. |
| PDX1 | Usually causes an isolated small pancreas without the heart defects seen in GATA6 [17][14]. |
| PTF1A | Mutations here are a known cause of a totally missing pancreas (agenesis) without heart defects [18][19]. |
| RFX6 | Causes Mitchell-Riley syndrome, which includes a small pancreas but also severe intestinal blockages (atresia) and gallbladder issues [20][21]. |
Knowing your child has a GATA6 mutation specifically helps their care team monitor for the right complications—like planning lesion-specific cardiac follow-up or tracking blood sugar changes as they grow—ensuring that their care is tailored to their unique genetic blueprint [22][23].
Common questions in this guide
What is GATA6 syndrome and what parts of the body can it affect?
What does it mean if GATA6 syndrome is de novo?
Can a healthy parent pass a GATA6 change to a child?
Which genetic tests are used to diagnose GATA6 syndrome?
What tests check whether the pancreas and heart are affected?
How do doctors tell GATA6 syndrome apart from similar genetic conditions?
Get notified when new evidence is published on Pancreatic hypoplasia-diabetes-congenital heart disease syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (23)
- 1
GATA6 Cooperates with EOMES/SMAD2/3 to Deploy the Gene Regulatory Network Governing Human Definitive Endoderm and Pancreas Formation.
Chia CY, Madrigal P, Denil SLIJ, et al.
Stem cell reports 2019; (12(1)):57-70 doi:10.1016/j.stemcr.2018.12.003.
PMID: 30629940 - 2
GATA6 mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm.
Sharma A, Wasson LK, Willcox JA, et al.
eLife 2020; (9()).
PMID: 33054971 - 3
GATA6 regulates WNT and BMP programs to pattern precardiac mesoderm during the earliest stages of human cardiogenesis.
Bisson JA, Gordillo M, Kumar R, et al.
bioRxiv : the preprint server for biology 2025; doi:10.1101/2024.07.09.602666.
PMID: 39026742 - 4
Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development.
Shi ZD, Lee K, Yang D, et al.
Cell stem cell 2017; (20(5)):675-688.e6 doi:10.1016/j.stem.2017.01.001.
PMID: 28196600 - 5
Novel GATA6 mutations in patients with pancreatic agenesis and congenital heart malformations.
Chao CS, McKnight KD, Cox KL, et al.
PloS one 2015; (10(2)):e0118449 doi:10.1371/journal.pone.0118449.
PMID: 25706805 - 6
A NONSENSE GATA6 MUTATION EXPLAINS HISTORY OF CONGENITAL HEART DEFECTS AND 10 YEARS OF POORLY-CONTROLLED DIABETES LACKING DKA IN A NON-OBESE 30 YEAR-OLD INCIDENTALLY FOUND TO HAVE PANCREATIC HYPOPLASIA.
Miles ML, Cowan N, Jackson G
AACE clinical case reports 2020; (6(3)):e123-e126 doi:10.4158/ACCR-2019-0156.
PMID: 32524025 - 7
Case report: maternal mosaicism resulting in inheritance of a novel GATA6 mutation causing pancreatic agenesis and neonatal diabetes mellitus.
Yau D, De Franco E, Flanagan SE, et al.
Diagnostic pathology 2017; (12(1)):1 doi:10.1186/s13000-016-0592-1.
PMID: 28049534 - 8
Case report: adult onset diabetes with partial pancreatic agenesis and congenital heart disease due to a de novo GATA6 mutation.
Sanchez-Lechuga B, Saqlain M, Ng N, et al.
BMC medical genetics 2020; (21(1)):70 doi:10.1186/s12881-020-01012-2.
PMID: 32245430 - 9
Novel pathogenic GATA6 variant associated with congenital heart disease, diabetes mellitus and necrotizing enterocolitis.
Yasuhara J, Manivannan SN, Majumdar U, et al.
Pediatric research 2024; (95(1)):146-155 doi:10.1038/s41390-023-02811-y.
PMID: 37700164 - 10
The Changing Landscape of Neonatal Diabetes Mellitus in Italy Between 2003 and 2022.
Rapini N, Delvecchio M, Mucciolo M, et al.
The Journal of clinical endocrinology and metabolism 2024; (109(9)):2349-2357 doi:10.1210/clinem/dgae095.
PMID: 38408297 - 11
Genome, Exome, and Targeted Next-Generation Sequencing in Neonatal Diabetes.
De Franco E, Ellard S
Pediatric clinics of North America 2015; (62(4)):1037-53.
PMID: 26210631 - 12
The Identification of a Novel Pathogenic Variant in the GATA6 Gene in a Child with Neonatal Diabetes.
Sechko EA, Koltakova MP, Khusainova RI, et al.
International journal of molecular sciences 2024; (25(22)) doi:10.3390/ijms252211998.
PMID: 39596087 - 13
Imaging Modalities in Congenital Heart Disease.
Sachdeva S, Gupta SK
Indian journal of pediatrics 2020; (87(5)):385-397 doi:10.1007/s12098-020-03209-y.
PMID: 32285327 - 14
PDX1 -MODY and dorsal pancreatic agenesis: New phenotype of a rare disease.
Caetano LA, Santana LS, Costa-Riquetto AD, et al.
Clinical genetics 2018; (93(2)):382-386 doi:10.1111/cge.13044.
PMID: 28436541 - 15
Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA.
Denson AM, Rodriguez KE, Letourneau-Freiberg LR, et al.
The Journal of clinical endocrinology and metabolism 2026; (111(4)):e1164-e1173 doi:10.1210/clinem/dgaf473.
PMID: 41006196 - 16
GATA4 and GATA6 regulate pancreatic endoderm identity through inhibition of hedgehog signaling.
Xuan S, Sussel L
Development (Cambridge, England) 2016; (143(5)):780-6 doi:10.1242/dev.127217.
PMID: 26932670 - 17
Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
Wang X, Sterr M, Burtscher I, et al.
Molecular metabolism 2018; (9()):57-68 doi:10.1016/j.molmet.2018.01.011.
PMID: 29396371 - 18
Clinical Characteristics and Long-term Follow-up of Patients with Diabetes Due To PTF1A Enhancer Mutations.
Demirbilek H, Cayir A, Flanagan SE, et al.
The Journal of clinical endocrinology and metabolism 2020; (105(12)) doi:10.1210/clinem/dgaa613.
PMID: 32893856 - 19
Pancreatic Agenesis due to Compound Heterozygosity for a Novel Enhancer and Truncating Mutation in the PTF1A Gene.
Gabbay M, Ellard S, De Franco E, Moisés RS
Journal of clinical research in pediatric endocrinology 2017; (9(3)):274-277 doi:10.4274/jcrpe.4494.
PMID: 28663161 - 20
Neonatal diabetes due to a truncating RFX6 mutation in an extremely low birth weight preterm infant with Mitchell-Riley syndrome.
Mutlu B
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(9)):933-938 doi:10.1515/jpem-2026-0162.
PMID: 42332910 - 21
Mitchell-Riley Syndrome: Improving Clinical Outcomes and Searching for Functional Impact of RFX-6 Mutations.
Passone CGB, Vermillac G, Staels W, et al.
Frontiers in endocrinology 2022; (13()):802351 doi:10.3389/fendo.2022.802351.
PMID: 35813646 - 22
Monogenic Diabetes with GATA6 Mutations: Characterization of a Novel Family and a Comprehensive Analysis of the GATA6 Clinical and Genetics Traits.
Yue X, Luo Y, Wang J, Huang D
Molecular biotechnology 2024; (66(3)):467-474 doi:10.1007/s12033-023-00761-8.
PMID: 37204622 - 23
Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.
Lemelman MB, Letourneau L, Greeley SAW
Clinics in perinatology 2018; (45(1)):41-59 doi:10.1016/j.clp.2017.10.006.
PMID: 29406006
This page explains the genetics, inheritance, and diagnostic testing of GATA6 syndrome for informational purposes only and does not constitute medical advice. A genetics professional and your child's medical team should interpret test results and discuss imaging and family-planning decisions.